key: cord-0792267-qxv1m7h0 authors: Olumade, T. J.; Uzairue, L. I. title: Clinical characteristics of 4490 COVID-19 patients in Africa: A meta-analysis date: 2020-10-21 journal: nan DOI: 10.1101/2020.10.20.20215905 sha: f67e07c53b0d2e900aab994c260dbc50a640c0ad doc_id: 792267 cord_uid: qxv1m7h0 Introduction: The novel coronavirus disease-2019 (COVID-19) pandemic that started in December 2019 has affected over 39 million people and killed over 1.1 million people. While more studies are published to help us understand the virus, there is a dearth of studies on the clinical characteristics and associated outcomes of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on the African continent. Methods: We evaluated evidence from previous studies in Africa available in six databases between January 1 and October 6, 2020. Meta-analysis was then performed using Open-Meta Analyst software. Results: A total of seven studies including 4490 COVID-19 patients were included. The result of the meta-analysis showed 68.8% of infected patients were male. Common symptoms presented (with their incidences) were fever (42.8%), cough (33.3%), headache (11.3%), breathing problems (16.8%). Other minor occurring symptoms included diarrhea (7.5%), and rhinorrhea (9.4%). Fatality rate was 5.6%. Conclusion: This study presents the first description and analysis of the clinical characteristics of COVID-19 patients in Africa. The most common symptoms are fever, cough and breathing problems. A disease that was first reported in early December 2019 1 has led to a pandemic in 2020 that has resulted in about 39 million cases and over 1.1 million deaths as of 18th October, 2020 2 . Nearly every continent of the earth, except Antarctica, has felt the impact of the novel Coronavirus Disease 2019 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 3, 4 . It was predicted that Africa will be the worst hit with the pandemic, having no less than 223 million cases and more than 150,000 fatalities 3, 5 . However, eight months into the pandemic, this is not the case. The WHO African Region, comprising only 47 member states on the continent (without Djibouti, Egypt, Libya, Morocco, Somalia, Sudan and Tunisia), has reported only 3.2% of all COVID-19 cases (1, 259, 192 out of 39,596,858) and 2.6% of deaths (28,313 out of 1,107,374) globally as of October 18 th , 2020 2,6 . Nevertheless, to improve our understanding and management of this novel disease, it remains pertinent to define and analyze the clinical characteristics and outcomes of the disease in patients 7 . Several studies have described the clinical and epidemiological characteristics, risk factors, case management, and associated outcomes of different patient cohorts with COVID-19 globally 1,7-15 . Clinical features, diagnosis and treatment of COVID-19 have also been reviewed elsewhere 16 . However, there is limited information on the clinical characteristics of COVID-19 in patients in Africa. In this article, we describe a meta-analysis of the clinical characteristics of COVID-19 patients in Africa. PubMed, Google scholar, Scopus, The Cochrane Library, EMBASE, and Africa journal online (AJOL) were electronically searched to collect clinical studies on the clinical characteristics of COVID 19 from January 1, 2020 to October 6, 2020. We also performed a manual search of the reference lists of included studies to avoid omitting any eligible study. Only studies written in English language and published online were included. The following terms were used in search alone OR in combination: "Coronavirus" . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 21, 2020. . https://doi.org/10.1101/2020.10.20.20215905 doi: medRxiv preprint OR"2019 nCoV"OR"COVID 19"OR"SARS CoV 2" AND "Africa" OR "Comoros" OR "Djibouti" OR "Madagascar" OR "Malawi" OR "Seychelles" OR "Cameroon" OR "Central African Republic" OR "Chad" OR "Congo" OR "Equatorial Guinea" OR "Atlantic Islands" OR "Gabon" OR "Morocco" OR "South Sudan" OR "Sudan" OR "Botswana" OR "Lesotho" OR "Swaziland" OR "Benin" OR "Burkina Faso" OR "Cape Verde" OR "Ghana" OR "Guinea" OR "Guinea-Bissau" OR "Mauritania" OR "Niger" OR "Senegal" OR "Sierra Leone" OR "Togo" OR "Burundi" OR "Eritrea" OR "Ethiopia" OR "Kenya" OR "Mozambique" OR "Rwanda" OR "Somalia" OR "Tanzania" OR "Uganda" OR "Zambia" OR "Zimbabwe" OR "Angola" OR "Algeria" OR "Egypt" OR "Tunisia" OR "Namibia" OR "South Africa" OR "Gambia" OR "Liberia" OR "Mali" OR "Nigeria" AND English[lang]. Figure 1 shows the flow chart of the literature screening process. The inclusion criteria were as follows: (1) cohort studies, case control studies, and case series studies; (2) the study population included individuals diagnosed with COVID 19; (3) the primary outcomes were: clinical symptoms, signs, demographics and fatality rate, etc. The exclusion criteria were as follows: (1) overlapping or duplicate studies; (2) The epidemiological analysis with only secondary outcomes such as fatality rate, without the primary outcomes; (3) had no clinical indicators or lacking necessary data. Two reviewers, using the inclusion and exclusion criteria, independently selected the literature, and extracted data to an Excel database and any disagreement was resolved by consensus. Data extraction included the first author's surname and the date of publication of the article, study region/country, study design, sample size, age and outcome measurement data such as clinical symptoms. The included studies of this meta analyses were observational case series studies, so the British National Institute for Clinical Excellence (BNICE) was used to evaluate the study quality by the independent reviewers. The evaluation included 8 items and the total score was 8. Studies with a score greater than 4 were seen as high quality. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 21, 2020. . All the meta analyses were performed by using Open-Meta Analyst 17 Single arm meta analyses were carried out. The heterogeneity was quantified using the I 2 statistic. The random model was utilized for statistical heterogeneity between the results of each study. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 21, 2020. . https://doi.org/10.1101/2020.10.20.20215905 doi: medRxiv preprint A total of 1065 Records were identified during literature retrieval from databases. A total of 7 studies involving 4490 COVID-19 patients were included in this meta-analysis 8, 9, 15, [18] [19] [20] [21] ( Figure 1 and Table 1 ). All studies included in this meta-analysis were conducted in African countries. The characteristics of the studies included in this meta-analysis were published between June 1, 2020 to October 2, 2020. The quality score of the included studies ranged from 5 to 7 on a maximum scale of quality score of 8 using the NICE criteria 22 (Table 1) . The random effect model was used in the meta-analysis. Gender distribution showed that the proportion of male was 68.8% (95% CI, 64.6%-72.9%) with significant heterogeneity I 2 = 65.16%, p = 0.014 (Figure 2 ). The incidence of commonly encountered symptoms were as follows: Fever (42.8%, 95% CL 30.7%-54.9%), Cough (33.3%, 95% CL, 24.0%-42.5%), Headache (11.3%, 95%CL, 2.9%-25.4%), Breathing problem (16.8%, 95% CL, 4.5%-29.1%) Diarrhea (7.5%, 95%CL, 2.8%-12.2%) and Rhinorrhea (9.4%, 95% CL, 8.5%-10.4%) as show in Table 2 . The fatality rate in the 4490 patients included in the meta-analysis was 5.6% (95% CL, 2.7%-8.6%) with significant heterogeneity (I 2 =85.9%, p= <0.001) (Figure 3 ). Abdoul Aziz-Diouf et al. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 21, 2020. Total 4490 the key effort of most clinical studies. In this study, we evaluated evidence from previous studies in Africa and conducted this meta analysis to systematically review the clinical characteristics of COVID 19 patients on the continent between June 1 and October 2, 2020. Our analysis included 4490 COVID 19 patients from seven studies conducted in five countries (Morocco, Senegal, Uganda, Congo and Nigeria). To the best of our knowledge, . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted October 21, 2020. . Clinical characteristics of coronavirus disease 2019 in China WHO Coronavirus Disease (COVID-19) Dashboard.; 2020 The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model COVID-19: The New Threat Africa in the Path of Covid-19 What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria Clinical characteristics and outcomes of COVID-19 infection in nine pregnant women: A report from a Sub-Saharan African Country, Senegal Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis Clinicopathological characteristics of 8697 patients with COVID-19 in China: A meta-analysis Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit The Clinical Characteristics and Prognosis Factors of Mild-Moderate Patients With COVID-19 in a Mobile Cabin Hospital: A Retrospective Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical and Demographic Characteristics of COVID-19 Patients in Lagos, Nigeria: A Descriptive Study COVID-19): A Review of Clinical Features Closing the gap between methodologists and end-users: R as a computational back-end The epidemiological and clinical profile of covid-19 in children: Moroccan experience of the cheikh khalifa university center Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda Descriptive epidemiology of coronavirus disease 2019 in Nigeria Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses Clinical features, pathogenesis and immunobiology of severe acute respiratory syndrome Clinical characteristics of hospitalized patients with SARS CoV 2 infection: A single arm meta analysis Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice All authors declare no competing interests. TJO and LIU were both involved in the conceptualization, design, analysis, and writing of the manuscript. Both authors approved the final draft of the manuscript.